Major Depressive Disorder (MDD) is a debilitating condition characterized by persistent feelings of sadness, hopelessness, and a lack of interest in daily activities. Understanding its underlying causes and effective treatments is crucial for patient well-being. The Journal of Clinical Psychiatry provides a comprehensive look into MDD, offering evidence-based therapeutic approaches and the latest research findings. Our expert editors ensure content is relevant and actionable, aiding psychiatrists in offering holistic care to those grappling with depression.
Depression and Major Depressive Disorder
Page 29
Recently published articles about Depression (MDD)
Commentary
Discontinuing Antidepressants: How Can Clinicians Guide Patients and Drive Research?
November 26, 2019
This commentary discusses common decisional uncertainties surrounding antidepressant discontinuation syndrome in the clinical setting and seeks to outline a roadmap for clinicians to drive research on this important topic.
Letter to the Editor
BMI and Remission in Depressed Patients Receiving IV Ketamine
November 12, 2019
Few studies have evaluated optimal dosing of intravenous (IV) ketamine for treatment-resistant depression (TRD). This report analyzes data from previous studies of IV ketamine to assess the association between...
Original Research
Utility of Combinatorial Pharmacogenomics in Depression
October 31, 2019
This study sought to ascertain the extent that pharmacogenetic testing can inform treatment decisions among patients with treatment-resistant depression whose medications are subject to gene-drug interactions—read the article to...
